ICD-10 Coding for Neurofibromatosis(D33.0, D33.3U, D33.9B)
Learn about ICD-10 coding for neurofibromatosis, including NF1 and NF2. Understand clinical criteria, documentation requirements, and coding pitfalls.
Complete code families applicable to Neurofibromatosis
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| Q85.01 | Neurofibromatosis, type 1 | Use when NF1 is confirmed by clinical criteria or genetic testing. |
|
| Q85.02 | Neurofibromatosis, type 2 | Use when NF2 is confirmed by clinical criteria or genetic testing. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutNeurofibromatosis
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Neurofibromatosis.
Vague documentation of neurofibromatosis
Impact
Clinical: May lead to misdiagnosis or inappropriate treatment., Regulatory: Non-compliance with documentation standards., Financial: Potential for denied claims or audits.
Mitigation
Use specific clinical criteria in documentation., Ensure all relevant findings are recorded.
Using unspecified codes like Q85.00
Impact
Reimbursement: May lead to denied claims or reduced reimbursement., Compliance: Non-compliance with coding guidelines., Data Quality: Decreases accuracy of patient records.
Mitigation
Ensure specific criteria for NF1 or NF2 are documented and use Q85.01 or Q85.02 accordingly.
Use of unspecified codes
Impact
High risk of audit if unspecified codes are used without justification.
Mitigation
Always document specific criteria and use the most specific code available.